Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review

Código QR

Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review

Abstract Denosumab, a monoclonal antibody that specifically targets cytokine receptor activator of nuclear factor‐kappa B ligand (RANKL), is a potentially viable option in resistant aneurysmal bone cysts.

Guardado en:

Detalles Bibliográficos
Autores principales:	Pedram Fadavi, Amir Mohammad Arefpour, Ramyar Hariri, Maryam Vasheghani, Maryam Garousi, Farzad Taghizadeh‐Hesary
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	aneurysmal bone cyst denosumab management RANK ligand resistant Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/194a51330c38431eb7d573915ca4f657
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Descripción
Sumario:	Abstract Denosumab, a monoclonal antibody that specifically targets cytokine receptor activator of nuclear factor‐kappa B ligand (RANKL), is a potentially viable option in resistant aneurysmal bone cysts.